Stem cells and G-CSF for treating neuroinflammation in traumatic brain injury: Aging as a comorbidity factor

Journal of Neurosurgical Sciences

Volumn 58, Issue 3, 2014, Pages 145-149

  Dela Pena I ^a   Sanberg, P R ^a   Acosta, S ^a   Tajiri, N ^a   Lin, S Z ^b   Borlongan, C V ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Aging; Brain injuries; Stem cells

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

AFGHANISTAN; ARTICLE; BLOOD BRAIN BARRIER; BRAIN REGION; CELL AGING; CELL DIFFERENTIATION; CELL LOSS; CORD BLOOD STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; IRAQ; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PATIENT SAFETY; THERAPY EFFECT; TRAUMATIC BRAIN INJURY; AGING; ANIMAL; BRAIN INJURIES; COMORBIDITY; INFLAMMATION; PHYSIOLOGY; STEM CELL;

AGING; ANIMALS; BRAIN INJURIES; COMORBIDITY; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INFLAMMATION; STEM CELLS;

EID: 84916893692     PISSN: 03905616     EISSN: 18271855     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Acosta SA, Tajiri N, Shinozuka K, Ishikawa H, Grimmig B, Diamond D, Sanberg PR et al. Long-term upregulation of inflammation and suppression of cell proliferation in the brain of adult rats exposed to traumatic brain injury using the controlled cortical impact model. PlosOne 2013;8:e53376.
2. Fabrizio KS, Keltner NL. Traumatic brain injury in operation enduring freedom/operation Iraqi freedom: a primer. Nurs Clin North Am 2010;45:569-80.
3. Faul M, Xu L, Wald MM, Coronado VG Traumatic brain injury in the United States: Emergency department visits, hospitalizations and deaths. Atlanta (GA): Centers for Disease Control and Prevention, National Center for Injury Prevention and Control 2010.
4. Tajiri N, Acosta SA, Shahaduzzaman MD, Ishikawa H, Shinozuka K, Pabon M et al. Intravenous transplants of human adipose-derived stem cell protect the brain from traumatic brain injury-induced neurodegeneration and motor and cognitive and cognitive impairments: cell graft biodistribution and soluble factors in young and aged rats. J Neurosci 2014;34:313-6.
5. Azouvi P, Vallat-Azouvi C, Belmont A. Cognitive deficits after traumatic coma. Prog Brain Res 2009;177:89-110.
6. Wong D, Dahm J, Ponsford J. Factor structure of the depression anxiety stress scales in individuals with traumatic brain injury. Brain Inj 2013;27:1377-82.
7. Kaneko Y, Tajiri N, Yu S, Hayashi T, Stahl CE, Bae E et al. Nestin overexpression precedes caspase-3 upregulation in rats exposed to controlled cortical impact traumatic brain injury. Cell Med 2012;4:55-63.
8. Brasure M, Lamberty GJ, Sayer NA, Nelson NW, Macdonald R, Ouellette J et al. Participation after multidisciplinary rehabilitation for moderate to severe traumatic brain injury in adults: a systematic review. Arch Phys Med Rehabil 2013;94:1398-420.
9. Giustini A, Pistarini C, Pisoni C. Traumatic and nontraumatic brain injury. Handb Clin Neurol 2013;110:401-9.
10. Lu J, Gary KW, Neimeier JP, Ward J, Lapane KL. Randomized controlled trials in adult traumatic brain injury. Brain Inj 2012;13-14:1523-48.
11. Rolan T. Traumatic brain injury? What do we know? J Spec Oper Med 2013;13:45-50.
12. Twamley EW, Jak AJ, Dellis DC, Bondi MW, Lohr JB. Cognitive symptom management and rehabilitation therapy (CogSMART) for veterans with traumatic brain injury: pilot randomized controlled trial. J Rehab Res Dev 2014;51:59-70.
13. Mueller BK, Mueller R, Schoemaker H. Stimulating neuroregeneration as a therapeutic drug approach for traumatic brain injury. Br J Pharmacol 2009;157:675-85.
14. Lindvall O, Brundin P, Widner H, Rehncrona S, Gustavii B, Frackowiak R et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 1990;247:574-57.
15. Liu YP, lang BT, Baskaya MK, Dempsey RJ, Vemuganti R. The potential of neural stem cells to repair stroke-induced brain damage. Acta Neurophatol 2009;117:469-80.
16. Mahmood A, Lu D, Lu M, Chopp M. Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery 2003;53:697-702, discussion 702-3
17. Yang M, Donaldson AE, Jiang Y, Iacovitti L. Factors influencing the differentiation of dopaminergic traits in transplanted neural stem cells. Cell Mol Neurobiol 2003;23:851-64.
18. Huang HY, Chen L, Sanberg PR. Clinical achievements, obstacles, falsehoods, and future directions of cell-based neurorestoratology. Cell Transplant 2012;21:S3-S11.
19. Chen SJ, Chang CM, Tsai SK, Chang YL, Chou SJ, Huang SS, Tai LK et al. Functional improvement of focal cerebral ischemia injury by subdural transplantation of induced pluripotent stem cells with fibrin glue. Stem Cells Dev 2010;19:1757-67.
20. Newman MB, Davis CD, Kuzmin-Nichols N, Sanberg PR. Human umbilical cord blood (HUCB) cells for central nervous system repair. Neurotox Res 2003;5:355-68.
21. Newman MB, Misiuta I, Willing AE, Zigova T, Karl RC, Borlongan CV et al. Tumorigenicity issues of embryonic carcinoma-derived stem cells: relevance to surgical trials using NT2 and hNT neural cells. Stem Cells Dev 2005;14:29-43.
22. Sanberg PR, Eve DJ, Metcalf C, Borlongan CV. Advantages and challenges of alternative sources of adult-derived stem cells for brain repair in stroke. Prog Brain Res 2012;201:99-117.
23. Sanberg PR, Eve DJ, Cruz LE, Borlongan CV. Neurological disorders and the potential role for stem cells as a therapy. Br Med Bull 2012;101:163-81.
24. Sandoe J, Eggan K. Opportunities and challenges of pluripotent stem cell neurodegenerative disease models. Nat Neurosci 2013;16:780-9.
25. Herranz AS, Gonzalo-Gobernado R, Reimers D, Asensio MJ, Rodriguez-Serrano M, Bazan E. Applications of human umbilical cord blood cells in central nervous system regeneration. Curr Stem Cell Res Ther 2010;5:17-22.
26. Ilic D, Miere C, Lazic E. Umbilical cord blood cells: clinical trials in non-hematological disorders. Brit Med Bull 2012;102:43-57.
27. Ou Y, Yu S, Kaneko Y, Tajiri N, Bae EC, Chheda SH, Stahl CE. Intravenous infusion of GDNF gene-modified human umbilical cord blood CD34+ cells protects against cerebral ischemic injury in spontaneously hypertensive rats. Brain Res 2010;1366:217-25.
28. Garbozuva-Davis S, Willing AE, Saporta S, Bickford PC, Gemma C, Chen N et al. Novel cell therapy approaches for brain repair. Prog Brain Res 2006;157:207-22.
29. Copeland N, Harris D, Gaballa MA. Human umbilical cord blood stem cells, myocardial infarction and stroke. Clin Med 2009;9:342-5.
30. Sanberg PR, Willing AE, Garbuzova-Davis S, Saporta S, Liu G, Sanberg CD et al. Umbilical cord blood-derived stem cells and brain repair. Ann N Y Acad Sci 2005;1049:67-83.
31. Verina T, Fatemi A, Johnston MV, Comi AM. Pluripotent possibilities: human umbilical cord blood cell treatment after neonatal brain injury. Pediatr Neurol 2013;48:346-54.
32. Boltze J, Reich DM, Hau S, Reymann KG, Strassburger M, Lobsien D, Wagner DC et al. Assessment of neuroprotective effects of human umbilical cord blood mononuclear cell subpopulations in vitro and in vivo. Cell Transplant 2012;21:723-37.
33. Henning RJ, Shariff M, Eadula U, Alvarado F, Vasko M, Sanberg PR, Sanberg CD et al. Human cord blood mononuclear cells decrease cytokines and inflammatory cells in acute myocardial infarction. Stem Cells Dev 2008;17:1207-19.
34. Pimentel-Coelho PM, Rosado-de Castro PH, Barbosa da Fonseca LM, Otero RM. Umbilical cord blood mononuclear cell transplantation for neonatal hypoxic-ischemic encephalophaty. Pediatr Res 2012;71:464-73.
35. Acosta SA, Franzese N, Staples M, Weinbren NL, Babilonia M, Patel J et al. Human umbilical cord for transplantation therapy in myocardial infarction. J Stem Cell Res Ther 2013;1(Suppl 4):S4-005.
36. Lee EJ, Choi EK, Kang SK, Kim GH, Park JY, Kang HJ et al. N-cadherin determines individual variations in the therapeutic efficacy of human umbilical cord blood-derived mesenchymal stem cells in a rat model of myocardial infarction. Mol Ther 2012;20:155-67.
37. + cells in a rabbit model of myocardial infarction. Mol Cell Biochem 2014;387:91-100.
38. Kumar A, Loane DJ. Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention. Brain Behav Immun 2012;26(8):1191-201.
39. Walker PA, Shah SK, Jimenez F, Aroom KR, Harting MT, Cox CS Jr. Bone marrow-derived stromal cell therapy for traumatic brain injury is neuroprotective via stimulation of non-neurologic organ systems. Surgery 2012;152:790-3.
40. Woodlock T, Morganti-Kossmann MC. The role of markers of inflammation in traumatic brain injury. Front Neurol 2013;4:18.
41. Shyu WC, Lin SZ, Yang HI, Yang HI, Tzeng YS, Pang CY et al. Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation 2004;110:1847-54.
42. Sanchez-Ramos J, Song S, Sava V, Catlow B, Lin X, Mori T, Cao C et al. Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice. Neuroscience 2009;163:55-72.
43. Schabitz WR, Kollmar R, Schwaninger M, Juettler E, Bardutzky J, Scholzke MN et al. Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 2003;34:745-51.
44. Schneider A, Kruger C, Steigleder T, Weber D, Pitzer C, Laage R et al. The hematopoietic factor GCSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 2005;115:2083-98.
45. Sakowitz OW, Schardt C, Neher M, Stover JF, Untenberg AW, Kiening KL. Granulocyte colony-stimulating factor does not affect contusion size, brain edema or cerebrospinal fluid glutamate concentrations in rats following controlled cortical impact. Acta Neurochir Suppl 2006;96:139-43.
46. Yang DY, Chen YJ, Wang MF, Pan HC, Chen SY, Cheng FC. Granulocyte colony-stimulating factor enhances cellular proliferation and motor function recovery on rats subjected to traumatic brain injury. Neurol Res 2010;32:1041-9.
47. England TJ, Abaei M, Auer DP, Lowe J, Jones DR, Sare G, Walker M et al. Granulocyte-colony stimulating factor for mobilizing bone marrow stem cells in subacute stroke: the stem cell trial of recovery enhancement after stroke 2 randomized controlled trial. Stroke 2012;43:405-11.
48. Acosta S, Tajiri N, Shinozuka K, Ishikawa H, Sanberg P, Sanchez-Ramos J et al. Combination therapy of human umbilical cord blood and granulocyte colony stimulating factor reduces histopathological and motor impairments in an experimental model of chronic traumatic brain injury. PlosOne 2014;9:e90953.
49. Willing AE, Vendrame M, Mallery J, Cassady CJ, Davis CD, Sanchez-Ramos J et al. Mobilized peripheral blood cells administered intravenously produce functional recovery in stroke. Cell Transplant 2003;12:449-54.
50. Iskander A, Knight RA, Zhang ZG, Ewing JR, Shankar A, Varma NR et al. Intravenous administration of human umbilical cord blood-derived AC133+ endothelial progenitor cells in rat stroke model reduces infarct volume: magnetic resonance imaging and histological findings. Stem Cells Transi Med 2013;2:703-14.
51. Shahaduzzaman M, Golden JE, Green S, Gronda AE, Adrien E, Ahmed A et al. A single administration of human umbilical cord blood T cells produces long-lasting effects in the aging hippocampus. Age (Dordr) 2013;35:2071-87.
52. Zhao LR, Piao CS, Murikinati SR, Gonzalez-Toledo ME. The role of stem cell factor and granulocyte-colony stimulating factor in treatment of stroke. Recent Pat CNS Drug Discov 2013;8:2-12.
53. Hrtung T. Anti-inflammatory effects of granulocyte colony-stimulating factor. Curr Opin Hematol 1998;221-5.
54. Morita Y, Takizawa S, Kamiguchi H, Uesugi T, Kawada H, Takagi S. Administration of hematopoietic cytokines increases the expression of anti-inflammatory cytokine (IL-10) mRNA in the subacute phase after stroke. Neurosci Res 2007;58:356-60.
55. Toth ZE, Leker RR, Shahar T, Pastorino S, Szalavova I, Asemenev B, Key S et al. The combination of granulocyte colony-stimulating factor and stem cell factor significantly increases the number of bone marrow-derived endothelial cells in brains of mice following cerebral ischemia. Blood 2008;111:5544-52.
56. Stachura DL, Svoboda O, Campbell CA, Espin-Palazon R, Lau RP, Zon LI et al. The zebrafish granulocyte colony stimulating factors (Gcsfs): two paralogous cytokines and their roles in hematopoietic development and maintenance. Blood 2013;122:3918-28.
57. Borlongan CV. Bone marrow stem cell mobilization in stroke: a 'bonehead' may be good after all! Leukemia 2011;25:1674-86.
58. Yang M, Wei X, Li J, Heine LA, Rosenwasser R, Iacovitti L. Changes in host blood factors and brain glia accompanying the functional recovery after systemic administration of bone marrow stem cells in ischemic stroke rats. Cell Transplant 2010;19:1073-84.
59. Hawkins BE, Cowart JC, Parsley MA, Capra BA, Eidson KA, Hellmich HL et al. Effects of trauma, hemorrhage and resuscitation in aged rats. Brain Res 2013;1496:28-35.
60. Thurman DJ, Alverson C, Dunn KA, Guerrero J, Sniezek JE. Traumatic brain injury in the United States: A public health perspective. J Head Trauma Rehabil 1999;14:602-15.
61. Li M, Li F, Luo C, Shan Y, Zhang L, Qian Z et al. Immediate splenectomy decreases mortality and improves cognitive function of rats after severe traumatic brain injury. J Trauma 2011;141-7.
62. Rasouli J, Lekhrai R, Ozbalik M, Lalezari P, Casper D. Brain-spleen inflammatory coupling: a literature review. Einstein J Biol Med 2011;27:74-7.
63. Vendrame M, Gemma C, Pennypacker KR, Bickford PC, Davis Sanberg C, Sanberg PR et al. Cord blood rescues stroke-induced changes in splenocyte phenotype and function. Exp Neurol 2006;199:191-200.
64. Walker PA, Shah SK, Harting MT, Cox CS Jr. Progenitor cell therapies for traumatic brain injury: barriers and opportunities in translation. Dis Model Mech 2009;2:23-8.
65. Walker PA, Shah SK, Jimenez F, Gerber MH, Xue H, Cutrone R, Hamilton JA et al. Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: preserving the blood-brain barrier via an interaction with splenocytes. Exp Neurol 2010;225:341-52.
66. Dietel B, Cicha I, Kallmünzer B, Tauchi M, Yilmaz A, Daniel WG et al. Suppression of dendritic cell functions contributes to the anti-inflammatory action of granulocyte-colony stimulating factor in experimental stroke. Exp Neurol 2012;237:379-87.
67. Kadota R, Koda M, Kawabe J, Hashimoto M, Nishio Y, Mannoji C et al. Granulocyte colony-stimulating factor (G-CSF) protects oligodendrocyte and promotes hindlimb functional recovery after spinal cord injury in rats. PLosOne 2012;7:e50391
68. Solaroglu I, Cahill J, Tsubokawa T, Beskonakli E, Zhang JH. Granulocyte colony-stimulating factor protects the brain against experimental stroke via inhibition of apoptosis and inflammation. Neurol Res 2009;31:167-72.
69. Sehara Y, Hayashi T, Deguchi K, Zhang H, Tsuchiya A, Yamashita T et al. Decreased focal inflammatory response by G-CSF may improve stroke outcome after transient middle cerebral artery occlusion in rats. J Neurosci Res 2007;85:2167-74.
70. Lewis FD, Horn GJ. Traumatic brain injury: analysis of functional deficits and post-hospital rehabilitation outcomes. J Spec Oper Med 2013;13:56-61.